Why the study?
Does cardiac resynchronization therapy (CRT) result in different rates of major adverse cerebral and cardiovascular events (MACCE) in patients with cardiac sarcoidosis compared to those with dilated cardiomyopathy?
Does cardiac resynchronization therapy (CRT) result in different rates of major adverse cerebral and cardiovascular events (MACCE) in patients with cardiac sarcoidosis compared to those with dilated cardiomyopathy?
Patients with cardiac sarcoidosis receiving CRT have significantly worse long-term outcomes (higher MACCE rates) compared to those with dilated cardiomyopathy, suggesting caution in its application for this population.
Answers are grounded in this paper and cite their sources.
CRT outcomes in cardiac sarcoidosis warrant caution; small retrospective comparison leaves open equivalence to dilated cardiomyopathy.
INTRODUCTION: Cardiac resynchronization therapy (CRT) has been shown to be effective for patients with chronic heart failure; however, the efficacy of CRT in patients with cardiac sarcoidosis (CS) has not been established. METHODS: We compared the outcomes of patients with CS who received CRT to patients with dilated cardiomyopathy (DCM). The incidence of major adverse cerebral and cardiovascular events (MACCE) in 11 consecutive CS patients (8 females; mean age, 66 ± 8.0 years) who received CRT were compared with 29 DCM patients (9 females; mean age, 70 ± 8.9 years). RESULTS: Females and patients with previous right ventricular pacing were largely included in the comparison of CS and DCM patients (P < 0.05 and P < 0.0001, respectively). During the mean follow-up period (465 ± 383 days for CS and 729 ± 393 days for DCM), MACCE were evident in 9 patients (23%); specifically, 5 CS and 4 DCM patients developed MACCE (45% vs. 14%, P < 0.05), respectively. Kaplan-Meier survival analysis demonstrated that CS patients had a higher prevalence of MACCE than DCM patients (log rank = 6.306, P = 0.0120; and Wilcoxon = 7.1333, P = 0.0076). Based on univariate analysis, the etiology of CS was associated with MACCE. CONCLUSION: Our results suggest that the long-term outcome of CRT in patients with CS was very poor compared with DCM patients. Thus, caution should be exercised regarding the indication of CRT in patients with CS.
No takes yet. Share an insight, caveat, or question.
Yufu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: